Use of Implantable Loop Recorders to Unravel the Cause of Unexplained Syncope  by Puri, Aniket & Srivastava, Rohit Kumar
www.ipej.org 66
Review Article
Use of Implantable Loop Recorders to Unravel the Cause of 
Unexplained Syncope
Aniket Puri1, Rohit Kumar Srivastava2
1Associate Professor, Dept of Cardiology, Chhatrapati Shahuji Maharaj Medical University, 
Lucknow, India 
2 PhD scholar, Dept of Physiology, Chhatrapati Shahuji Maharaj Medical University, 
Lucknow, India 
Address for Correspondence: Dr .Aniket Puri, DM, FACC, FAPSIC, FSCAI, Associate 
Professor, Department of Cardiology, Chhatrapati Shahuji Maharaj Medical University, 
Lucknow, India. 
E mail: aniketpuri/at/hotmail.com 
Abstract
Syncope is  a symptom of  many underlying disease states,  which range from the relatively 
benign  to  the  life  threatening.  There  are  numerous  investigations  done  for  patients  with 
recurrent unexplained syncope which may have very low yield when it  comes to making a 
definitive diagnosis. Recently, the implantable loop recorder (ILR) for continuous monitoring 
of the cardiac rhythm has been launched in India. This review will briefly discuss these current 
available  strategies  and  focus  on  the  usefulness  of  an  ILR in  the  definitive  diagnosis  and 
treatment  of patients  with a recurrent unexplained syncope.                               
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Introduction
Syncope  is  an  abrupt  and  transient  loss  of  consciousness  (TLOC)  associated  with  loss  of 
postural tone that follows a sudden fall in cerebral perfusion. Syncope is a symptom of many 
underlying disease states, which range from the relatively benign to the life threatening [1]. At 
assessment,  patients  are  often  asymptomatic  and  the  diagnosis  is  unclear,  culminating  in 
frequent hospitalization and resulting in expensive and often repeated investigations, most of 
which  are  inconclusive  [2].                                                    
Syncope  accounts  for  approximately  3% of  emergency  room visits  and 1-6  % of  hospital 
admissions. The prevalence of syncope increases with age from 0.7% in men aged 35-44 to 
5.6% in  men  over  the  age  of  75.  In  long-  term care  institutions,  the  annual  incidence  is 
approximately 6 % [3]. The elderly represent the population at greater risk for most causes of 
syncope.  
Once it has been established that the patient has true syncope, it is useful to further classify into 
4  categories:  1)  reflex  neurally  mediated;  2)  cardiac;  3)  orthostatic  hypotension;  or  4) 
unexplained.    The major causes of syncope are enumerated in Table 1.
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Table 1: Different causes of syncope
Investigation of patients with recurrent unexplained syncope may include electrocardiography, 
ambulatory Holter monitoring, treadmill exercise testing, neurologic testing, tilt table testing 
and electrophysiological testing. Recently, a new device, an implantable loop recorder (ILR) 
has been developed for continuous monitoring of the cardiac rhythm to unravel the cause of 
unexplained syncope. This review will briefly discuss these current available  strategies and 
focus on the usefulness of an ILR in the definitive diagnosis and treatment of patients with a 
recurrent  unexplained  syncope.                                   
More commonly, a focused initial evaluation of syncope leads to a suspected diagnosis, which 
needs  to  be  confirmed  by directed  testing.  If  a  diagnosis  is  confirmed  by specific  testing, 
treatment may be initiated. On the other hand, if the diagnosis is not confirmed, then patients 
are considered to have unexplained syncope. The strategy of evaluation varies according to the 
severity and frequency of the episodes.  The majority of patients with single or rare episodes 
probably have neurally mediated syncope and tests for confirmation are usually not necessary. 
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If  it  is  not  clear  that  it  was  syncope,  the  term ‘transient  loss  of  consciousness  (TLOC) is  
preferable  and  reappraisal  is  warranted.                                            
Approach  to  assess  unexplained  syncope                                        
History, physical examination,  and electrocardiography are the core of the investigations  of 
syncope with a combined diagnostic yield of 50%. Neurological testing is rarely helpful unless 
additional  neurological  signs  or  symptoms  are  present  and  the  diagnostic  yield  for 
electroencephalography,  computed  tomography,  and  Doppler  ultrasound  is  only  6%  [4].
Clinical  history  and  physical  examination                                 
History should focus on postural symptom, palpitations, family history and should include the 
use of medication particularly in the elderly patients. Physical examination should focus on 
orthostatic blood pressure, cardiac murmurs and specific cardiac disorders e.g. aortic or mitral 
stenosis. The clinical features suggestive of a particular cause of syncope are enumerated in 
Table 2.  
Table 2: Clinical features suggestive of specific causes of syncope
Cardiac  diagnostic  approach                                     
Electrocardiography
Electrocardiography is essential in the work-up of patients with unexplained syncope but may 
reveal a direct cause in only 5 % of patients. Pre-excitation patterns, a long QT- interval, the 
recently reported Brugada syndrome and characteristic features in patients with arrhythmogenic 
right ventricular dysplasia should all be considered [5 -7]. Table 3
Echocardiography
No studies have been specifically designed to assess the usefulness of echocardiography in 
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syncope. However, in patients known to have or suspected of having heart disease, patients 
suspected of having arrhythmias, echocardiography is an important initial  step in diagnostic 
testing.  Unsuspected findings  on echocardiography are reported in only 5% to 10% of un-
selected patients  [8]. This yield is similar  to that of 12-lead electrocardiography.  The cost-
effectiveness of echocardiography in diagnosing the cause of syncope has yet to be determined. 
In  patients  with  exertional  syncope,  echocardiography  should  be  done  first  to  exclude 
hypertrophic cardiomyopathy.      
Table 3:  ECG abnormalities suggesting an arrhythmic syncope
Exercise  Testing                                             
Exercise  stress  testing  can  be  used  for  the  evaluation  of  exertional  syncope to  diagnose    
ischemia or exercise-induced tachyarrhythmia’s or to reproduce post exertional syncope. In one 
population study of patients with syncope, the yield of the exercise stress test was less than 1% 
[9]. Data is scarce to determine the yield for ischemia or exercise-induced tachyarrhythmia’s or 
to define the test's usefulness in diagnosing exercise-associated syncope. Exercise stress testing 
is  recommended  if  patients  have  exercise-associated  syncope  and  if  the  results  of  clinical 
evaluation  suggest  ischemic  heart  disease.                                             
Tilt  table  testing                                                  
Tilt table testing has emerged as a safe and effective method of identifying individuals with a 
susceptibility to neurally mediated syncope [10]. Tilt table testing may be performed alone or 
with pharmacological provocation using isoprenaline or nitrate preparations. The tilt table test 
is best considered for patients with suspected neurally mediated syncope but in whom the cause 
is not obvious or in patients with syncope of otherwise unknown origin with no evidence of 
heart disease. The major problem with tilt table testing is quantifying the test’s sensitivity. The 
sensitivity of the test has been calculated at between 20% and 75% [11]. In those known to 
have structural heart disease in which electrophysiological studies have not given a diagnostic 
clue,  tilt  table  testing  may  prove  cost-effective  by  avoiding  expensive  and  unrewarding 
neurological  investigations  such as computed  tomography or  electroencephalography which 
might otherwise be requested. Interestingly, the frequency of syncope decreases following a 
positive  test  regardless  of  therapeutic  intervention.  The  test  may  educate  the  patient  to 
recognize the warning signs of syncope and to make appropriate changes in posture. [12, 13]
Holter monitoring 
A 24-hour Holter  monitor  or  inpatient  telemetry  is  recommended  when symptoms suggest 
arrhythmic syncope with brief loss of consciousness, no prodrome, palpitations with syncope 
and  in  patients  who  have  syncope  of  unexplained  cause,  heart  disease,  or  an  abnormal 
electrocardiogram.  
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Neurological  diagnostic  approach                                     
Neurologic tests used for patients with syncope include electroencephalography, brain imaging 
(computed tomography or magnetic resonance imaging), and neurovascular studies (carotid and 
transcranial doppler ultrasonographic studies). To determine which patients may benefit from 
neurologic testing, physicians should take a particularly careful neurologic history for example, 
patients should be asked about a history of seizure activity, prolonged loss of consciousness, 
diplopia,  headache,  and  post  ictal  symptoms  and  perform  a  thorough,  focused  physical 
examination including a search for bruits or focal neurologic signs. A diagnostic algorithm and 
approach to a patient with syncope is suggested in  Figure 1.                                
Figure 1. Flow chart for the diagnostic approach to the patient with syncope using an implantable loop recorder
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New  method  of  monitoring  to  diagnose  syncope:  "Implantable  loop  recorder"  (ILR)
In spite of a detailed screening of patients and often multidisciplinary investigation, more than 
one third of the patients may remain undiagnosed [14]. Recently, an implantable loop recorder 
(ILR) has been developed for continuous monitoring of the cardiac rhythm to unravel the cause 
of unexplained syncope. The ILR is an implantable device that has a solid state loop memory 
capable of storing electrocardiographic events up to 40 minutes before and 1 to 2 minutes after 
activation. The ILR has built in electrodes on the back of the device to detect patients’ cardiac 
rhythm and does not require any intra cardiac leads. This device is very small and is typically  
implanted subcutaneously in the left pectoral region as an out-patient procedure [15]. Currently, 
there are 2 FDA-approved ILRs available for clinical use as shown in Figure 2. The REVEAL 
PLUS device  (MEDTRONIC, Minneapolis, USA) was the first approved device, it is about 62 
× 19 × 8 mm in size and the battery of the device generally lasts 18 months. The CONFIRM 
device (ST JUDE, St Paul, USA), it is about 56.3 × 18.5 × 8 mm in size and its battery is 
expected to last up to 3 years. Data are retrieved and analyzed with a compatible programmer 
but this device also has a remote real-time monitoring capability that allows patients to send 
data directly to their health care providers.[16]  
Figure 2: Two type of ILR, the REVEAL PLUS device (MEDTRONIC, Minneapolis, USA) is about 62 × 19 × 8 
mm in size and the CONFIRM device (ST JUDE, St Paul, USA) , it is about 56.3 × 18.5 × 8 mm in size         
Method  of  Implantation                                             
After identification of the most appropriate pectoral position to record an electrocardiographic 
lead with a prominent QRS wave, the loop recorder is subcutaneously implanted snugly in a 
pocket similar to that of a pacemaker implantation, the size of a little finger. After suture of the 
skin, the quality of electrocardiographic recording is tested in supine and standing positions and 
during movements of both the arms. The device is explanted after a diagnosis is obtained or if 
syncope did not recur. The first experiences with the ILR have shown that the device was safe 
and was able to detect cardiac arrhythmias in about 23-42% of patients. The population in these 
studies was, however, not systematically evaluated prior to the ILR implantation to reach a 
diagnosis.  [17]                                             
Clinical  evaluation  of  the  ILR                                            
In  an  initial  study  of  24  patients,  52% presented  with  an  arrhythmic  cause  with  the  vast 
majority of patients having bradycardia. Treatment was directed at the underlying cause in the 
18 patients who received a specific diagnosis. During follow up, syncope did not occur in 16 of 
the18 treated patients. In 2 patients who underwent explantation of the device after the end of 
battery life, no recurrence was seen with a final analysis extending the follow-up to 40 ± 10 
months[18].  A  larger  series  of  85  patients  with  recurrent  undiagnosed  syncope  despite 
extensive evaluation had patients who were eligible if they had at least two syncopal episodes 
within the previous 2 months or if they had a single syncope with a history of presyncope. In all 
patients ILR was implanted which resulted in detection of abnormal rhythms in 21 patients, the 
vast majority having a bradycardia. Interestingly,  in 29 patients no arrhythmia was detected 
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despite  symptoms.  Patients  with  syncope were more  likely  to  record  an arrhythmia  during 
symptoms compared to patients with a history of presyncope (70 % vs 24 % p = 0.005)[19]. 
Recently another large and prospective study was carried out to collect information on the use 
of the REVEAL (MEDTRONIC, Minneapolis, USA) ILR in the patient care pathway and to 
investigate  its  effectiveness  in  the  diagnosis  of  unexplained  recurrent  syncope in  everyday 
clinical practice. Eligible patients had recurrent unexplained syncope or pre-syncope. Follow 
up was until the first recurrence of a syncopal event leading to a diagnosis or till the end of 1  
year.  In  the  course  of  the  study,  patients  were  evaluated  by  an  average  of  three  different 
specialists  for  management  of  their  syncope and underwent  a  median  of 13 tests.  Average 
follow-up time after ILR implant was 10±6months. The percentages of patients with recurrence 
of syncope were 19%, 26% and 36% after 3, 6 and 12 months respectively. Of 218 events 
within the study, ILR-guided diagnosis was obtained in 170 cases (78%), of which 128 (75%) 
were of cardiac origin.[20] The findings support the recommendation in current guidelines that 
an ILR should be implanted early rather than late in the evaluation of unexplained syncope.  
Recently we conducted a similar work and enrolled 20 patients of unexplained syncope, out of 
which 11 patients completed a 12 month, follow up. The diagnostic yield was 100% in the 11 
patients among which 7 patients got permanent pacemaker implantation and 4 patients having 
no  arrhythmic  event  noted  with  symptoms  and  9  patients  continue  in  follow  up.  [21]
Therapy  Guided  by  ILR                                     
Little  is  known about  the  outcome  after  ILR-guided  specific  therapy.  In  the  East  Bourne 
Syncope Assessment Study [22], performed in a typical unselected population, there was an 
increased diagnostic rate in the group of patients randomized to ILR management and ECG-
directed  treatments  than  in  conventional  investigation  group.  Despite  that  a  specific  ILR 
directed  therapy  could  be  applied  to  only  a  minority  of  patients,  the  long-term follow-up 
demonstrated a significant reduction in syncopal events with improved quality of life with ILR 
based treatment. Since prolonged asystole was the most frequent finding at the time of syncope, 
pacing was the specific therapy mostly used in the ILR population. In a pooled data of 720 ILR 
patients from 4 studies, a pacemaker was implanted in 17% of patients, with 45% of those 
having  an  ILR-documented  event.  In  the  ISSUE  2  study,  the  1-year  burden  of  syncope 
decreased from 0.83±1.57 episodes per patient per year in the control group of patients without 
any ILR-guided specific  therapy to 0.05±0.15 episodes per  patient  per  year  in  the patients 
treated with a ILR-guided specific therapy of pacemaker (87% relative risk reduction; P=.001). 
[23] In another study, after the insertion of a cardiac pacemaker,  syncope burden decreased 
from 2.17 per year to 0.45 per year in 1A or 1B group syncope patients (P=.02) and from 4.57 
per year to 0 per year in the type 1C syncope patients (P=.001). Nevertheless, syncope still 
recurred  in  12% (range,  3%–18%) of the patients  during the long-term follow up (2.0–3.6 
years), especially in those patients more likely to be affected by neurally mediated syncope, 
accounting  for  the  coexistence  of  some  vasodepressor  reflex  that  cannot  be  overcome  by 
pacing. Implantable cardioverter-defibrillator and radiofrequency catheter ablation were also 
consistently  used  in  a  few  selected  patients  with  ILR  documented  ventricular  and  atrial 
tachyarrhythmia’s in 1.5% and 3.0% of the patients, respectively [23].                              
Limitation  of  the  device                                              
Limitations of the device include the inability to monitor blood pressure changes, the necessity 
for surgical implant, cost of the device and a small risk of infection. Most patients in whom an 
arrhythmia  is  not  documented  during  syncope  have  either  hypotensive  syndromes  or 
psychogenic  syncope.  Hypotensive  syndromes  include  vasovagal  syncope,  orthostatic 
hypotension,  postprandial  hypotension,  and  vasodepressor  carotid  carotid  sinus 
hypersensitivity.  A facility to track blood pressure behavior in addition to heart rate during 
symptoms would undoubtedly advance real-time hemodynamic monitoring with implantable 
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devices. The inability of the present device to detect hypotension is a limitation and in the near 
future the devices capable of recording other physiological parameters may further increase the 
diagnostic  yield  [24].  With  increasing  healthcare  costs,  a  proper  selection  of  patients  for 
implantation of an ILR  is mandatory. Total costs of the investigation of patients with recurrent 
syncope are high because of extensive diagnostic testing [25]. However in a cost analysis study 
it was demonstrated that ILR implantation could reduce costs as was seen in a pilot study of 24 
patients referred for recurrent syncope [26]. There may also be a small risk of interference from 
electronic  article  surveillance  devices  and  found  that  interference  may  occur  causing 
malfunction  of  this  device  [27].                                               
Conclusion
The  prognosis  of  syncope  ranges  from  benign  to  life  threatening  situations  and  risk 
stratification  should  be  based  on  the  result  of  history,  physical  examination, 
electrocardiography, and selected noninvasive test. ILR is a novel and useful diagnostic tool in 
patients  with  unexplained  syncope.  ILR  is  easy  to  implant  and  explant  and  is  based  on 
electrocardiography which is useful to establish if there is an arrhythmic cause of syncope, 
especially  when  symptoms  are  recurrent  but  too  infrequent  for  conventional  monitoring 
techniques.      
Table 4. Summary of Recommendations
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